|
BRPI0515973B8
(pt)
|
2004-10-12 |
2021-07-27 |
Fmc Biopolymer As |
kit para produzir um gel de alginato, composição para preparar um gel e uso
|
|
EP1910322B1
(en)
|
2005-07-29 |
2012-09-05 |
Concert Pharmaceuticals Inc. |
Novel deuterated benzo [d][1,3]-dioxol derivatives as serotonin reuptake inhibitors
|
|
US8796267B2
(en)
|
2006-10-23 |
2014-08-05 |
Concert Pharmaceuticals, Inc. |
Oxazolidinone derivatives and methods of use
|
|
US8080549B2
(en)
|
2007-01-12 |
2011-12-20 |
Concert Pharmaceuticals, Inc. |
Endothelin receptor antagonists
|
|
US8071596B2
(en)
|
2007-01-12 |
2011-12-06 |
Concert Pharmaceuticals, Inc. |
Endothelin receptor antagonists
|
|
EP2125717B1
(en)
|
2007-02-26 |
2013-07-03 |
Concert Pharmaceuticals Inc. |
Deuterated derivatives of silodosin as alpha ia-adrenoreceptor antagonists
|
|
EP2139877B1
(en)
|
2007-03-07 |
2011-05-11 |
Concert Pharmaceuticals Inc. |
Deuterated piperazine derivatives as anti-anginal compounds
|
|
CA2681628C
(en)
|
2007-03-16 |
2016-10-18 |
Concert Pharmaceuticals, Inc. |
Inhibitors of cholesterol ester transfer protein
|
|
WO2008128166A1
(en)
|
2007-04-13 |
2008-10-23 |
Concert Pharmaceuticals Inc. |
Deuterated derivatives of 4-(6-fluoro-1, 2-benzisoxazol-3-yl) piperidine compounds
|
|
US8349817B2
(en)
|
2007-04-25 |
2013-01-08 |
Concert Pharmaceuticals, Inc. |
Analogues of cilostazol
|
|
EP2152689B1
(en)
|
2007-04-25 |
2013-01-02 |
Concert Pharmaceuticals Inc. |
Analogues of cilostazol
|
|
DK3825306T3
(da)
|
2007-05-01 |
2023-09-11 |
Sun Pharmaceutical Ind Inc |
Morphinanforbindelser
|
|
MX370608B
(es)
|
2007-05-01 |
2019-12-18 |
Concert Pharmaceuticals Inc |
Compuestos de morfinano.
|
|
US7820666B2
(en)
|
2007-05-08 |
2010-10-26 |
Concert Pharmaceuticals, Inc. |
Tetrahydrotriazolopyrazine derivatives and uses thereof
|
|
MX2009013565A
(es)
|
2007-06-12 |
2010-06-02 |
Concert Pharmaceuticals Inc |
Derivados de azapeptidos.
|
|
US7687509B2
(en)
|
2007-07-09 |
2010-03-30 |
Concert Pharmaceuticals Inc. |
Pyrimidinecarboxamide derivatives
|
|
WO2009023233A1
(en)
|
2007-08-14 |
2009-02-19 |
Concert Pharmaceuticals, Inc. |
Substituted oxazolidinone derivatives
|
|
JP2010537717A
(ja)
|
2007-08-28 |
2010-12-09 |
エフ エム シー コーポレーション |
遅効性自己ゲル化アルギネートシステムおよびその用途
|
|
ES2406479T3
(es)
|
2007-09-12 |
2013-06-07 |
Concert Pharmaceuticals Inc. |
Derivado deuterado de 4-oxoquinolina para el tratamiento de la infección por VIH
|
|
CN101855218A
(zh)
|
2007-09-13 |
2010-10-06 |
康塞特医药品有限公司 |
氘化的儿茶酚和苯并[d][1,3]间二氧杂环戊烯及其衍生物的合成
|
|
WO2009051782A1
(en)
|
2007-10-18 |
2009-04-23 |
Concert Pharmaceuticals Inc. |
Deuterated etravirine
|
|
US8592487B2
(en)
|
2007-10-26 |
2013-11-26 |
Concert Pharmaceuticals, Inc. |
Deuterated darunavir
|
|
US8084464B2
(en)
|
2007-12-18 |
2011-12-27 |
Concert Pharmaceuticals, Inc. |
Tetrahydroisoquinoline derivatives
|
|
WO2009094210A1
(en)
|
2008-01-22 |
2009-07-30 |
Concert Pharmaceuticals Inc. |
Vandetanib derivatives
|
|
WO2009094216A1
(en)
|
2008-01-22 |
2009-07-30 |
Concert Pharmaceuticals Inc. |
Derivatives of gefitinib
|
|
CA2716788C
(en)
|
2008-02-29 |
2016-08-16 |
Concert Pharmaceuticals, Inc. |
Deuterium-substituted xanthine derivatives
|
|
US8367674B2
(en)
|
2008-04-17 |
2013-02-05 |
Concert Pharmaceuticals, Inc. |
Piperazine derivatives
|
|
WO2009154754A2
(en)
|
2008-06-17 |
2009-12-23 |
Concert Pharmaceuticals, Inc. |
Synthesis of deuterated morpholine derivatives
|
|
KR20110063479A
(ko)
|
2008-08-29 |
2011-06-10 |
콘서트 파마슈티컬즈, 인크. |
치환된 트리아졸로-피리다진 유도체
|
|
US8704001B2
(en)
|
2008-09-16 |
2014-04-22 |
Concert Pharmaceuticals, Inc. |
Deuterated 2-amino-3-hydroxypropanoic acid derivatives
|
|
EP2805950B1
(en)
|
2008-09-19 |
2017-11-08 |
Concert Pharmaceuticals, Inc. |
Deuterated morphinan compounds
|
|
US9045453B2
(en)
|
2008-11-14 |
2015-06-02 |
Concert Pharmaceuticals, Inc. |
Substituted dioxopiperidinyl phthalimide derivatives
|
|
US20120077803A1
(en)
*
|
2009-02-24 |
2012-03-29 |
Novartis Ag |
Uses Of NK Receptor Antagonists
|
|
US8952016B2
(en)
|
2009-02-27 |
2015-02-10 |
Concert Pharmaceuticals, Inc. |
Substituted xanthine derivatives
|
|
US8263601B2
(en)
|
2009-02-27 |
2012-09-11 |
Concert Pharmaceuticals, Inc. |
Deuterium substituted xanthine derivatives
|
|
DE102009001446A1
(de)
|
2009-03-10 |
2010-09-23 |
Evonik Rohmax Additives Gmbh |
Verwendung von Kammpolymeren als Antifatigue-Additive
|
|
BRPI1009199A2
(pt)
|
2009-03-17 |
2016-03-08 |
Concert Pharmaceuticals Inc |
compostos de pirazinoisoquinolina
|
|
WO2010108103A1
(en)
*
|
2009-03-19 |
2010-09-23 |
Concert Pharmaceuticals, Inc. |
Azepan-2-one derivatives
|
|
DK2421808T3
(da)
|
2009-04-23 |
2013-11-04 |
Concert Pharmaceuticals Inc |
4-Hydroxysmørsyreanaloger
|
|
WO2010135579A1
(en)
|
2009-05-22 |
2010-11-25 |
Concert Pharmaceuticals, Inc. |
Fluorinated diaryl urea derivatives
|
|
AU2010260249B2
(en)
|
2009-06-18 |
2013-09-05 |
Concert Pharmaceuticals, Inc. |
Deuterated isoindoline-1,3-dione derivatives as PDE4 and TNF-alpha inhibitors
|
|
WO2011005520A1
(en)
|
2009-06-23 |
2011-01-13 |
Concert Pharmaceuticals, Inc. |
Deuterium-modified triazolo-pyridazine derivatives as gaba-a receptor modulators
|
|
EP2464355A4
(en)
|
2009-08-14 |
2013-01-02 |
Concert Pharmaceuticals Inc |
SUBSTITUTED TRIAZOLPHTHALAZINE DERIVATIVES
|
|
WO2011028820A1
(en)
|
2009-09-02 |
2011-03-10 |
Concert Pharmaceuticals, Inc. |
Substituted derivatives of bicyclic [4.3.0] heteroaryl compounds
|
|
WO2011047315A1
(en)
|
2009-10-15 |
2011-04-21 |
Concert Pharmaceuticals, Inc. |
Subsitituted benzimidazoles
|
|
WO2011063001A1
(en)
|
2009-11-18 |
2011-05-26 |
Concert Pharmaceuticals, Inc. |
Niacin prodrugs and deuterated versions thereof
|
|
DE102010001040A1
(de)
|
2010-01-20 |
2011-07-21 |
Evonik RohMax Additives GmbH, 64293 |
(Meth)acrylat-Polymere zur Verbesserung des Viskositätsindexes
|
|
WO2011109464A1
(en)
|
2010-03-02 |
2011-09-09 |
Concert Pharmaceuticals Inc. |
Deuterated tetrahydronaphthalene derivatives
|
|
US8575361B2
(en)
|
2010-03-02 |
2013-11-05 |
Concert Pharmaceuticals Inc. |
Tetrahydronaphthalene derivatives
|
|
US9226801B2
(en)
*
|
2010-03-08 |
2016-01-05 |
Ibur, Llc |
Custom linkable imaging and multifunctional tray
|
|
US8575221B2
(en)
|
2010-03-17 |
2013-11-05 |
Concert Pharmaceuticals, Inc. |
Derivatives of dimethylcurcumin
|
|
US9107922B2
(en)
|
2010-07-16 |
2015-08-18 |
Concert Pharmaceuticals, Inc. |
Pyrimidinecarboxamide derivatives
|
|
US9085788B2
(en)
|
2010-09-01 |
2015-07-21 |
Concert Pharmaceuticals, Inc. |
Process for preparing an enantiomerically enriched, deuterated secondary alcohol from a corresponding ketone without reducing deuterium incorporation
|
|
US9074233B2
(en)
|
2010-09-01 |
2015-07-07 |
Concert Pharmaceuticals, Inc. |
Process for preparing an enantiomerically enriched, deuterated secondary alcohol from a corresponding ketone without reducing deuterium incorporation
|
|
CN103370289B
(zh)
|
2011-02-14 |
2015-09-09 |
康塞特医药品有限公司 |
4-羟基丁酸氘化类似物
|
|
US9145390B2
(en)
|
2011-03-03 |
2015-09-29 |
Concert Pharmaceuticals, Inc. |
Derivatives of pyrazole-substituted amino-heteroaryl compounds
|
|
WO2012122028A2
(en)
|
2011-03-04 |
2012-09-13 |
Concert Pharmaceuticals Inc. |
Pyrazinoisoquinoline compounds
|
|
HUE047354T2
(hu)
|
2011-05-18 |
2020-04-28 |
Vertex Pharmaceuticals Europe Ltd |
Ivacaftor deuterizált származékai
|
|
CN104364255A
(zh)
|
2012-04-13 |
2015-02-18 |
康塞特医药品有限公司 |
取代的黄嘌呤衍生物
|
|
US9249093B2
(en)
|
2012-04-20 |
2016-02-02 |
Concert Pharmaceuticals, Inc. |
Deuterated rigosertib
|
|
US20150197525A1
(en)
|
2012-06-15 |
2015-07-16 |
Concert Pharmaceuticals, Inc. |
Deuterated derivatives of ruxolitinib
|
|
US9181190B2
(en)
|
2012-07-04 |
2015-11-10 |
Concert Pharmaceuticals, Inc. |
Deuterated vercirnon
|
|
ES2694202T3
(es)
|
2012-07-12 |
2018-12-19 |
Concert Pharmaceuticals, Inc. |
Idebenona deuterada
|
|
EA201590296A1
(ru)
|
2012-07-30 |
2015-07-30 |
Консерт Фармасьютикалс Инк. |
Дейтерированный ибрутиниб
|
|
EP2885303B1
(en)
|
2012-08-17 |
2018-12-26 |
CoNCERT Pharmaceuticals, Inc. |
Deuterated baricitinib
|
|
WO2014066243A1
(en)
|
2012-10-22 |
2014-05-01 |
Concert Pharmaceuticals, Inc. |
Solid forms of {s-3-(4-amino-1-oxo-isoindolin-2yl)(piperidine-3,4,4,5,5-d5)-2,6-dione}
|
|
ES2672468T3
(es)
|
2013-01-09 |
2018-06-14 |
Concert Pharmaceuticals Inc. |
Momelotinib deuterado
|
|
WO2014150043A1
(en)
|
2013-03-15 |
2014-09-25 |
Concert Pharmaceuticals Inc. |
Inhibitors of the enzyme udp-glucose: n-acyl-sphingosine glucosyltransferase
|
|
US8906951B1
(en)
|
2013-06-24 |
2014-12-09 |
Tigercat Pharma, Inc. |
Use of NK-1 receptor antagonists in pruritus
|
|
US9198898B2
(en)
|
2013-06-24 |
2015-12-01 |
Tigercat Pharma, Inc. |
Use of NK-1 receptor antagonists in pruritus
|
|
WO2015031741A1
(en)
|
2013-08-30 |
2015-03-05 |
Concert Pharmaceuticals, Inc. |
Deuterated derivatives of a thienotriazolodiazapine bromodomain-containing protein inhibitor
|
|
CN106459056A
(zh)
|
2014-02-10 |
2017-02-22 |
康塞特医药品公司 |
经取代的三唑苯二氮卓
|
|
US10160778B2
(en)
|
2014-10-27 |
2018-12-25 |
Concert Pharmaceuticals, Inc. |
Pyrimidine phosphonic acid esters
|
|
US10196384B2
(en)
|
2015-03-31 |
2019-02-05 |
Vertex Pharmaceuticals (Europe) Limited |
Deuterated CFTR modulators
|
|
WO2016176335A1
(en)
|
2015-04-27 |
2016-11-03 |
Concert Pharmaceuticals, Inc. |
Deuterated otx-015
|
|
CA2999529A1
(en)
|
2015-09-25 |
2017-03-30 |
Vertex Pharmaceuticals (Europe) Limited |
Deuterated cftr potentiators
|
|
US11267777B2
(en)
|
2015-11-19 |
2022-03-08 |
Concert Pharmaceuticals, Inc. |
Deuterated EPI-743
|
|
US10442761B2
(en)
|
2016-02-16 |
2019-10-15 |
Concert Pharmaceuticals, Inc. |
Deuterated GFT-505
|
|
WO2019104179A1
(en)
|
2017-11-22 |
2019-05-31 |
Concert Pharmaceuticals, Inc. |
Deuterated analogs of d-serine and uses thereof
|
|
WO2019109021A1
(en)
|
2017-12-01 |
2019-06-06 |
Vertex Pharmaceuticals Incorporated |
Processes for making modulators of cystic fibrosis transmembrane conductance regulator
|
